Evidence map›Paper›PMID 26425429›Full record

ArticleBeilstein journal of nanotechnology2015

Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory.

Marina E Vance, Todd Kuiken, Eric P Vejerano, Sean P McGinnis, Michael F Hochella, David Rejeski, Matthew S Hull

Abstract read
In one paragraph

Article in Beilstein journal of nanotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 383 papers.

0numbers the graph read from it
0cells of the map it votes in
383citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

383 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. FeNanomaterials (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Journal of proteome research · 2025
    Article
  18. Article
  19. Review
  20. Nanoimprinted Materials for Nanoparticle Sensing and Removal.Nanomaterials (Basel, Switzerland) · 2025
    Review

323 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marina E VanceInstitute for Critical Technology and Applied Science, Virginia Tech, 410 Kelly Hall (0194), 235 Stanger St., Blacksburg, VA 24061, United States.
Todd KuikenWoodrow Wilson International Center for Scholars, One Woodrow Wilson Plaza - 1300 Pennsylvania Ave., NW, Washington, DC 20004, United States.
Eric P VejeranoDepartment of Civil & Environmental Engineering, Virginia Tech, 418 Durham Hall (0246), Blacksburg, VA 24061, United States.
Sean P McGinnisDepartment of Materials Science and Engineering, Virginia Tech, Holden Hall (0237), Blacksburg, VA 24061, United States.
Michael F HochellaDepartment of Geosciences, Virginia Tech, 4044 Derring Hall (0420), Blacksburg, VA 24061, United States.
David RejeskiWoodrow Wilson International Center for Scholars, One Woodrow Wilson Plaza - 1300 Pennsylvania Ave., NW, Washington, DC 20004, United States.
Matthew S HullInstitute for Critical Technology and Applied Science, Virginia Tech, 410 Kelly Hall (0194), 235 Stanger St., Blacksburg, VA 24061, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To document the marketing and distribution of nano-enabled products into the commercial marketplace, the Woodrow Wilson International Center for Scholars and the Project on Emerging Nanotechnologies created the Nanotechnology Consumer Products Inventory (CPI) in 2005. The objective of this present work is to redevelop the CPI by leading a research effort to increase the usefulness and reliability of this inventory. We created eight new descriptors for consumer products, including information pertaining to the nanomaterials contained in each product. The project was motivated by the recognition that a diverse group of stakeholders from academia, industry, and state/federal government had become highly dependent on the inventory as an important resource and bellweather of the pervasiveness of nanotechnology in society. We interviewed 68 nanotechnology experts to assess key information needs. Their answers guided inventory modifications by providing a clear conceptual framework best suited for user expectations. The revised inventory was released in October 2013. It currently lists 1814 consumer products from 622 companies in 32 countries. The Health and Fitness category contains the most products (762, or 42% of the total). Silver is the most frequently used nanomaterial (435 products, or 24%); however, 49% of the products (889) included in the CPI do not provide the composition of the nanomaterial used in them. About 29% of the CPI (528 products) contain nanomaterials suspended in a variety of liquid media and dermal contact is the most likely exposure scenario from their use. The majority (1288 products, or 71%) of the products do not present enough supporting information to corroborate the claim that nanomaterials are used. The modified CPI has enabled crowdsourcing capabilities, which allow users to suggest edits to any entry and permits researchers to upload new findings ranging from human and environmental exposure data to complete life cycle assessments. There are inherent limitations to this type of database, but these modifications to the inventory addressed the majority of criticisms raised in published literature and in surveys of nanotechnology stakeholders and experts. The development of standardized methods and metrics for nanomaterial characterization and labelling in consumer products can lead to greater understanding between the key stakeholders in nanotechnology, especially consumers, researchers, regulators, and industry.

Indexed as

consumer productsdatabaseinventorynanoinformaticsnanomaterials

Identifiers

PMID26425429
PMCPMC4578396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.